Work

Consolidation Therapy of Probiotics With Rifaximin Prevent Relapse in Rifaximin‐Responsive Diarrhea‐Predominant Irritable Bowel Syndrome: A Multicenter Randomized Clinical Trial

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Gastroenterology and Hepatology

DOI: 10.1111/jgh.70672

Authors: Jing Zhong, Zhengyang Xu, Wenwen Chen, Yao Jiang, Qiwei Ge, Yanyong Deng, Weili He, Xinli Mao, Yabi Zhu, Jianzhong Sang, Peifen Zheng, Linhua Yao, Feng Han, Huaqiang You, Shujie Chen, Liangjing Wang

Institutions: Second Affiliated Hospital of Zhejiang University, Zhejiang University, Sir Run Run Shaw Hospital, Lishui Central Hospital, Zhejiang Taizhou Hospital, Lishui City People's Hospital, Zhejiang Hospital, First Hospital of Jiaxing

Language: English

Topic: Gastrointestinal motility and disorders

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Natural Science Foundation of Zhejiang Province

Award: 基于IRF5 基因敲除小鼠模型探究NLRP3 炎症小体介导溃疡性结肠炎的分子机制研究

OpenAlex ID: W7203702828

FWCI: 5.245

Cites: 21

Cited by: 1

Related to: